Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about PRPF31: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
PRPF31 (Prp31) is a key spliceosome component essential for U4/U6.U5 tri-snRNP assembly and catalytic spliceosome activation. This comprehensive page covers its structure, normal neuronal function, role in neurodegenerative diseases, and therapeutic potential.
No AI portrait yet
| Gene Symbol | PRPF31 |
| Aliases | Prp31 |
| Chromosome | 19q13.42 |
| Function | The tri-snRNP contains |
| Molecular Weight | 55.6 kDa |
| Amino Acids | 499 aa |
| UniProt ID | O94973 |
| NCBI Gene ID | 26121 |
| Ensembl ID | ENSG00000105618 |
| OMIM | 607395 |
| GeneCards | PRPF31 |
| Human Protein Atlas | PRPF31 |
| U4 snRNA | serves as an intronic sequence placeholder |
| U6 snRNA | the catalytic component of the spliceosome |
| U5 snRNA | recognizes the 5' and 3' splice sites |
| Associated Diseases | neurodegeneration |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
PRPF31["PRPF31"]
neurodegeneration["neurodegeneration"]
PRPF31 -->|"implicated in"| neurodegeneration
Neurodegenerative_Diseases{"Neurodegenerative Diseases"}
PRPF31 -->|"implicated in"| Neurodegenerative_Diseases
style PRPF31 fill:#1a4a3a,stroke:#81c784,stroke-width:3px,color:#fff
style Neurodegenerative_Diseases fill:#4a1a1a,stroke:#ef5350,stroke-width:1px,color:#ef5350| Target | Relation | Type | Str |
|---|---|---|---|
| No outgoing edges | |||
| Source | Relation | Type | Str |
|---|---|---|---|
| No incoming edges | |||
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning PRPF31 in their description or question text
No additional research found